Yoon lab:Research: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
|-valign="top" | |-valign="top" | ||
|style="background:#ffffff"| | |style="background:#ffffff"| | ||
== <font face="candara" size=4 style="color:#db631f">'''Research'''</font> == | |||
<font face="candara" size=3.5 style="color:#000000"> | |||
The BEL is currently working in three areas: | |||
</font> | |||
== <font face="candara" size=3 style="color:#db631f">'''1. Translational Bio-friendly Materials'''</font> == | |||
{| cellspacing="3" | |||
|- valign="top" | |||
|width=420px class="white"| | |||
<font face="candara" size=3 style="color:#000000"><p align="justify" style="line-height:100%"> | |||
Biomaterials that can be introduced into the human body hold great potential to diagnose and treat disease. For such applications, it is important that the materials be harmlessly eliminated from the body in a reasonable period of time after they carry out their diagnostic or therapeutic functions. For example, despite efforts to improve their targeting efficiency, significant quantities of systemically administered nanomaterials are cleared by the mononuclear phagocytic system before finding their targets, increasing the likelihood of unintended acute or chronic toxicity. However, there has been little effort to engineer the self-destruction of errant biomaterials into non-toxic, systemically eliminated products. In the BEL, we are developing clinically relevant biosafe materials that can perform their unique biological functions without any toxicity concerns. | |||
|width=270px class="MainPageBG" style="background-color: white"| | |||
[[Image:Si-1.png|250px|right|thumb|<font face="candara" size=2 style="color:#000000">The element symbol for silicon spelled out on a fingertip with bio-friendly luminescent silicon nanoparticles.</font>]] | |||
</p> |
Revision as of 15:15, 17 October 2010
ResearchThe BEL is currently working in three areas: 1. Translational Bio-friendly Materials
|